Dr. Fred Beasley discusses how to improve experimental design and select the most appropriate animal models for your preclinical obesity research.
When conducting preclinical obesity research using animal models, researchers must consider many factors. They must select an appropriate model, define long-term dosing requirements and mitigate complications including subject-to-subject variability and regressions to and from an obese state arise.
In this webinar hosted by CrownBio, Dr. Fred Beasley presents tips and best practices for designing obesity studies, including how to choose the right animal model, best fit for study criteria and specific diet acceptance.
Crown Bioscience brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today's most pressing challenges in oncology, inflammation, cardiovascular, and metabolic disease. Our premier Translational Platforms help our clients accelerate their new drug development programs.
Additional Content From Crown Bioscience
What’s Next in Preclinical Cancer Immunotherapy Research?
This webinar will include a panel discussion of key topics in the field of cancer immunotherapy, including new and emerging methods, recent publications, and future directions.
Analyzing the Suppressive TME in in Vitro Based Assays
Experts describe suppressive tumor immune microenvironment compartments and patient-derived tissue technologies capable of recapitulating the TME for clinically-relevant studies.
Targeting T Cells Within the Cancer Immunity Cycle
In this webinar, speakers will discuss the role of T cell biology in cancer immunotherapy.
Measurement of Cardiac Function Using Pressure-Volume Loops in Swine
Join Dr. Pedro Ferreira for a deep dive into his work using pressure-volume loops in large animal models of heart failure.
Peripheral and Cerebral Vascular Responses Following High-Intensity Interval Exercise
Dr. Bert Bond and Max Weston present an overview on their study investigating the effects high-intensity interval exercise has on cerebrovascular health.
Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection and Management
Artur Fedorowski, MD, PhD, describes cardiovascular dysautonomia in COVID-19 and the diagnostics behind detecting Long COVID or Post-acute Sequalae of COVID-19.